Maravai LifeSciences

Thrilled to announce that one of our very own, Chanfeng Zhao, has been named to the 2024 PharmaVoice 100!   According to Zhao, 'mRNA’s unstoppable future is bright.' With billions of doses administered during the COVID-19 pandemic, mRNA’s safety and potential have been proven globally. The mRNA field is expanding rapidly, with over 250 cancer therapies and 500 treatments for other diseases in development. She emphasizes the importance of pushing boundaries, driven by passion and collaboration to fuel innovation.   Chanfeng - Congratulations! We are so proud to have you as part of the TriLink BioTechnologies, part of Maravai LifeSciences team.   Find the article here: https://lnkd.in/gydHwkUU   #PharmaVoice #LeadersInScience #mRNA #Biotech

⭐ This Monday's #MiracleMaker is Mark Gianino, a Quality Control Supervisor TriLink BioTechnologies, part of Maravai LifeSciences!   A former high school chemistry teacher, Mark was drawn back to industry by his love of being in the lab. He has been with the company since 2020 and after serving in a few roles of increasing responsibility, he is now a supervisor with analytical services within TriLink GMP.   Want to be a #MiracleMaker? Explore open roles below: https://lnkd.in/et6kyMar #MiracleMakers #EmployeeSpotlight #Innovators #Innovation

The Maravai LifeSciences Foundation is proud to support the Crohn's & Colitis Foundation and to celebrate the 10th annual Champions of Hope Gala.  Innovation is not just a buzzword at Maravai; it’s a way of life. We understand that the challenges to improve human health demand unprecedented solutions. Our focus on developing cutting-edge technologies that enable our customers to unlock new approaches and address unmet medical needs, combined with events like these, embody a deep dedication to driving positive change and pushing the boundaries of what’s possible. We commend the Crohn’s and Colitis Foundation for its work accelerating research, providing education, support, and advocacy programs to help find cures and improve the lives of those affected by Crohn's or Colitis. #ChampionsOfHope #CrohnsColitisFoundation #ResearchForCures

⭐ This Monday's #MiracleMaker is Lauren Edwards, a Quality Control Analytical Services Manager at TriLink BioTechnologies, part of Maravai LifeSciences!   An outdoors adventurer at heart, Lauren spends her days managing the Tech Transfer team within the Analytical Services department. With a background in analytical chemistry, she has applied her knowledge of analytical instrumentation to a variety of roles in her career.   Want to be a #MiracleMaker? Explore open roles below: https://lnkd.in/et6kyMar   #MiracleMakers #EmployeeSpotlight #Innovators #Innovation

TriLink BioTechnologies, part of Maravai LifeSciences, is excited to announce that we have expanded our Discovery mRNA synthesis services offerings with custom sets of mRNA. Our new 𝗰𝘂𝘀𝘁𝗼𝗺 𝘀𝗲𝘁𝘀 𝗼𝗳 𝗺𝗥𝗡𝗔 provide the flexibility and amount of mRNA you need for 𝘀𝗰𝗿𝗲𝗲𝗻𝗶𝗻𝗴 (0.1 mg) and 𝗵𝗶𝘁-𝘁𝗼-𝗹𝗲𝗮𝗱 𝗼𝗽𝘁𝗶𝗺𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝘀𝘁𝘂𝗱𝗶𝗲𝘀 (0.1 to 0.5 mg). Expedite your mRNA discovery work today!   Learn more: https://lnkd.in/gMQBqeP7 #RNA #mRNAsynthesis #screening #leadoptimization #newproduct

🐾 Our finance and accounting team at Maravai LifeSciences had an amazing time volunteering with the Rancho Coastal Humane Society, assembling dog gift boxes and beds!   John Van Zante from Rancho Coastal summed it up perfectly: "This event not only helps the animals, but it also brings a sense of pride and fulfillment to everyone involved." In the midst of the ongoing shelter crisis, where so many dogs are in need of care, initiatives like these have never been more important. We're proud to support such a wonderful cause with a team building event and make a positive impact in our community!   Watch the full video at WROC-TV Channel 8: https://lnkd.in/geuf8MSt #VolunteerWork #CommunityImpact #AnimalCare #GivingBack #Teamwork

TriLink BioTechnologies, part of Maravai LifeSciences is excited to announce that we have collaborated with Alphazyme LLC to launch CleanScribe™ RNA Polymerase, a novel enzyme that reduces double-stranded RNA (dsRNA) in mRNA production. The new product reduces dsRNA by up to 85%, helping to develop safer, more potent mRNA therapeutics.    Learn more: https://lnkd.in/gVDcY3Dd #RNA #announcement #mRNA #enzymes #productlaunch

As the global conversation intensifies around avian flu and mpox (formerly known as monkeypox), Kate Broderick, PhD, Chief Innovation Officer at Maravai LifeSciences, has been quoted alongside notable industry experts like Dr. Jay K. Varma, from SIGA Technologies, and Brian Ferguson, Professor of Immunology at the University of Cambridge.   In light of the World Health Organization's recent designation of mpox as a Public Health Emergency of International Concern (PHEIC), these leaders emphasize the critical need for proactive measures in combating emerging infectious diseases. Dr. Broderick, who has spearheaded innovation in mRNA therapeutics, continues to lead efforts at TriLink BioTechnologies, part of Maravai LifeSciences to advance next-generation tech in vaccine development and beyond.   👉Learn more about the insights shared by these experts and how they are shaping the future of global health: https://lnkd.in/ePGJzTHS #HealthcareInnovation #GlobalHealth #Biotech #PandemicPreparedness #PublicHealth

Maravai LifeSciences and We are Empowered (WE) ERG were deeply honored to host Katalin Karikó, PhD, Nobel-Prize-winning scientist and pioneering researcher in mRNA technology, for an insightful talk and book signing with our team at our TriLink BioTechnologies, part of Maravai LifeSciences facility.   Her groundbreaking work in mRNA therapies has revolutionized modern medicine, saving countless lives and reshaping the future of healthcare. Hearing her story firsthand was an unforgettable experience, reminding us of the profound difference one individual can make with vision and determination. In recognition of her great influence, along with Dr. Drew Weissman, we have named conference rooms after each of them at our new Flanders buildings - a small way to honor them and remember how they have changed the course of history.   Thank you, Dr. Karikó, for your invaluable time, for sharing your awe-inspiring journey with us, and for showing the world the power of science and innovation!

⭐ This Monday's #MiracleMaker is Shelby Yuhas, a Scientist at Glen Research!   After graduating from The Johns Hopkins University in 2020, Shelby was doing postdoctoral research with small molecule inhibitors for DNA repair enzymes when she heard about a Scientist role with Glen Research. Bringing her vast structural and analytical experience in everything from enzyme kinetics, organic synthesis, cell biology, phosphonamidites, chromatographic techniques, and more, Shelby joined the Glen team in May 2021 and has been helping colleagues and customers to use Glen products and solve problems.   Want to be a #MiracleMaker? Explore open roles below: https://lnkd.in/et6kyMar #MiracleMakers #EmployeeSpotlight #Innovators #Innovation